These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

438 related items for PubMed ID: 9230743

  • 81.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 82. Effect of increasing doses of hypertonic saline on mucociliary clearance in patients with cystic fibrosis.
    Robinson M, Hemming AL, Regnis JA, Wong AG, Bailey DL, Bautovich GJ, King M, Bye PT.
    Thorax; 1997 Oct; 52(10):900-3. PubMed ID: 9404379
    [Abstract] [Full Text] [Related]

  • 83.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 84. Rheological Properties of Cystic Fibrosis Bronchial Secretion and in Vitro Drug Permeation Study: The Effect of Sodium Bicarbonate.
    Stigliani M, Manniello MD, Zegarra-Moran O, Galietta L, Minicucci L, Casciaro R, Garofalo E, Incarnato L, Aquino RP, Del Gaudio P, Russo P.
    J Aerosol Med Pulm Drug Deliv; 2016 Aug; 29(4):337-45. PubMed ID: 26741302
    [Abstract] [Full Text] [Related]

  • 85. Hypertonic saline treatment of cystic fibrosis.
    Taylor LM, Kuhn RJ.
    Ann Pharmacother; 2007 Mar; 41(3):481-4. PubMed ID: 17327291
    [Abstract] [Full Text] [Related]

  • 86.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 87.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 88. Mucolytic therapy in cystic fibrosis.
    Wallis C.
    J R Soc Med; 2001 Mar; 94 Suppl 40(Suppl 40):17-24. PubMed ID: 11601159
    [No Abstract] [Full Text] [Related]

  • 89. Amiloride inhalation therapy in cystic fibrosis. Influence on ion content, hydration, and rheology of sputum.
    Tomkiewicz RP, App EM, Zayas JG, Ramirez O, Church N, Boucher RC, Knowles MR, King M.
    Am Rev Respir Dis; 1993 Oct; 148(4 Pt 1):1002-7. PubMed ID: 8214916
    [Abstract] [Full Text] [Related]

  • 90. Hyaluronic acid improves the tolerability of hypertonic saline in the chronic treatment of cystic fibrosis patients: a multicenter, randomized, controlled clinical trial.
    Ros M, Casciaro R, Lucca F, Troiani P, Salonini E, Favilli F, Quattrucci S, Sher D, Assael BM.
    J Aerosol Med Pulm Drug Deliv; 2014 Apr; 27(2):133-7. PubMed ID: 23745525
    [Abstract] [Full Text] [Related]

  • 91.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 92. Nebulized hypertonic saline and recombinant human DNase in the treatment of pulmonary atelectasis in newborns.
    Dilmen U, Karagol BS, Oguz SS.
    Pediatr Int; 2011 Jun; 53(3):328-31. PubMed ID: 20831650
    [Abstract] [Full Text] [Related]

  • 93.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 94. Overnight delivery of hypertonic saline by nasal cannula aerosol for cystic fibrosis.
    Corcoran TE, Godovchik JE, Donn KH, Busick DR, Goralski J, Locke LW, Markovetz MR, Myerburg MM, Muthukrishnan A, Weber L, Lacy RT, Pilewski JM.
    Pediatr Pulmonol; 2017 Sep; 52(9):1142-1149. PubMed ID: 28737262
    [Abstract] [Full Text] [Related]

  • 95.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 96. DNA quantification and fragmentation in sputum after inhalation of recombinant human deoxyribonuclease.
    Riethmueller J, Vonthein R, Borth-Bruhns T, Grassmé H, Eyrich M, Schilbach K, Stern M, Gulbins E.
    Cell Physiol Biochem; 2008 Sep; 22(1-4):347-52. PubMed ID: 18769062
    [Abstract] [Full Text] [Related]

  • 97.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 98. Effects of rhDNase on purulent airway secretions in chronic bronchitis.
    Puchelle E, Zahm JM, de Bentzmann S, Grosskopf C, Shak S, Mougel D, Polu JM.
    Eur Respir J; 1996 Apr; 9(4):765-9. PubMed ID: 8726943
    [Abstract] [Full Text] [Related]

  • 99.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 100.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 22.